| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Review |
From the Department of Pathology (Neuropathology) and Neuroscience Graduate Program, University of Virginia, Charlottesville, Virginia
Abstract
Until recently, the investigation of protein phosphorylation was limited to biochemical studies of enzyme activities in homogenized tissues. The availability of hundreds of phosphorylation state-specific antibodies (PSSAs) now makes possible the study of protein phosphorylation in situ, and is opening many exciting opportunities in investigative and diagnostic pathology. This review illustrates the power of PSSAs, especially in immunohistochemical applications to human disease and animal models. Technical considerations, including antibody specificity and lability of phosphoepitopes, are covered, along with potential pitfalls, illustrated by a case study. In the arena of oncology, PSSAs may prove especially valuable in directly demonstrating the efficacy of chemotherapies targeted at protein kinase cascades. Novel applications of PSSAs are also beginning to reveal molecular mechanisms of inflammatory, degenerative, and toxin-induced diseases.
This article has been cited by other articles:
![]() |
T. Miyamoto, N. Oshiro, K.-i. Yoshino, A. Nakashima, S. Eguchi, M. Takahashi, Y. Ono, U. Kikkawa, and K. Yonezawa AMP-activated Protein Kinase Phosphorylates Golgi-specific Brefeldin A Resistance Factor 1 at Thr1337 to Induce Disassembly of Golgi Apparatus J. Biol. Chem., February 15, 2008; 283(7): 4430 - 4438. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mottok, C. Renne, K. Willenbrock, M.-L. Hansmann, and A. Brauninger Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6 Blood, November 1, 2007; 110(9): 3387 - 3390. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Khan, T. A. Ponzio, G. Sanchez-Watts, B. G. Stanley, G. I. Hatton, and A. G. Watts Catecholaminergic Control of Mitogen-Activated Protein Kinase Signaling in Paraventricular Neuroendocrine Neurons In Vivo and In Vitro: A Proposed Role during Glycemic Challenges J. Neurosci., July 4, 2007; 27(27): 7344 - 7360. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Nyalendo, M. Michaud, E. Beaulieu, C. Roghi, G. Murphy, D. Gingras, and R. Beliveau Src-dependent Phosphorylation of Membrane Type I Matrix Metalloproteinase on Cytoplasmic Tyrosine 573: ROLE IN ENDOTHELIAL AND TUMOR CELL MIGRATION J. Biol. Chem., May 25, 2007; 282(21): 15690 - 15699. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lassmann, I. Schuster, A. Walch, H. Gobel, U. Jutting, F. Makowiec, U. Hopt, and M. Werner STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation J. Clin. Pathol., February 1, 2007; 60(2): 173 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Renne, K. Willenbrock, R. Kuppers, M.-L. Hansmann, and A. Brauninger Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma Blood, May 15, 2005; 105(10): 4051 - 4059. [Abstract] [Full Text] [PDF] |
||||
![]() |
Vet. Pathol., March 1, 2004; 41(2): 201 - 202. [Full Text] [PDF] |
||||
![]() |
E. Floyd and T. M. Mcshane Development and Use of Biomarkers in Oncology Drug Development Toxicol Pathol, January 1, 2004; 32(1_suppl): 106 - 115. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |